== Legionnaires disease diagnostic assessments N/ANot relevant, BALbronchoalveolar lavage, PCRpolymerase chain reaction aNon-Legionella pneumophila Demographics, medical comorbidities and risk factors are presented in Table2
== Legionnaires disease diagnostic assessments N/ANot relevant, BALbronchoalveolar lavage, PCRpolymerase chain reaction aNon-Legionella pneumophila Demographics, medical comorbidities and risk factors are presented in Table2. disease in the Niagara Region from the Province of Ontario, Canada, from June to December 2013. == Results == From June to December 2013, there have been 14 hospitalized cases of Legionnaires disease in the Niagara Region. Of those, 86 % (12 patients) had at least 1 comorbidity and 71 % (10 patients) were cigarette smokers. In our cohort, Legionnaires disease was diagnosed with a mix of a urinaryLegionellaantigen test and aLegionellareal-time polymerase chain reaction assay. Delay in effective antimicrobial therapy in the treatment ofLegionellainfection led to clinical deterioration. Almost all patients had met systemic inflammatory response syndrome criteria with fever > 38 C (71 %), heart rate > 90 beats per minute (71 %), and respiratory rate > 20 breaths per minute (86 %). Eleven patients (79 %) required admission to the intensive treatment unit or step-down unit, and nine patients (64 %) required intubation. Clinical improvement after initiation of antimicrobials was protracted. AHU-377 (Sacubitril calcium) == Conclusions == Legionnaires disease should be considered during the late spring and summer months in individuals with a history of tobacco use and various comorbidities. Clinically, patients presented AHU-377 (Sacubitril calcium) with severe, nonspecific, multisystem disease characterized by shortness of breath, abnormal vital signs, AHU-377 (Sacubitril calcium) and laboratory derangements including hyponatremia, elevated creatine kinase, and evidence of organ dysfunction. In addition , antimicrobial therapy with newer macrolides or respiratory fluoroquinolones should be initiated for severe community-acquired pneumonia requiring rigorous care unit admission, AHU-377 (Sacubitril calcium) prior to laboratory confirmation of diagnosis, especially when a clinical suspicion ofLegionellainfection is present. Keywords: Legionella pneumophila, Legionnaires disease, Community-acquired pneumonia == Background == Legionella pneumophila, a gram-negative bacteria and the main causative agent of legionellosis, was first recognized in 1976 [1]. Legionellosis has two distinct clinical presentations: (1) Pontiac fever, a self-limited, febrile, flulike illness; and (2) Legionnaires disease. Legionnaires disease is usually an atypical pneumonia that has clinical and radiographic findings similar to those of pneumococcal pneumonia [26]. It has an incubation period of 214 days. Patients may present with fever, cough, myalgia, asthenia, anorexia, and relative bradycardia [2]. Symptoms that are more suggestive of Legionnaires disease include gastrointestinal symptoms (diarrhea, nausea, vomiting, and abdominal pain) and neurologic symptoms (headache, obtundation, seizures, and focal neurologic findings) [2, 710]. Legionnaires disease is also characterized by nonspecific laboratory findings such as hyponatremia; hypophosphatemia; leukocytosis with family member lymphopenia; raised creatine kinase, erythrocyte sedimentation rate, C-reactive protein, and ferritin levels; myoglobulinuria; and microscopic hematuria [2]. Legionnaires diseases accounts for 215 % of hospitalized community-acquired pneumonia (CAP) and up to 30 % of CAP requiring intensive treatment unit (ICU) admission [11, 12]. The incidence of Legionnaires disease increased by 192 % in the United States between 2000 and 2009 to 11. 5 cases per 1 million populace [13]. Sixty-two percent of the cases occur in the summer and autumn seasons. This is due to the increased utilization of air-conditioning systems and cooling AHU-377 (Sacubitril calcium) towers as well as to increased rainfall [14, 15]. Approximately 20 % of cases were travel-associated [16]. Only 4 % of cases were associated with a known outbreak [2]. The risk factors for Legionnaires disease include cardiopulmonary disease, cigarette smoking, age group > 50 years, diabetes, malignancy, and immunosuppressive state including glucocorticoid use [11, 17]. Legionnaires disease causes significant morbidity and carries a mortality price Mouse monoclonal to BMPR2 of 812 % [18]. Among patients who also survive, recovery is often slower, and they are left with fatigue, neurologic and neuromuscular symptoms, and post-traumatic stress disorder [19]. Legionnaires disease is also very costly, with a healthcare-associated cost of more than $23, 000 per case [20]. The diagnosis of Legionnaires disease can be made using non-culture- and culture-based techniques [2]. A urinary antigen test that detects a component from the cell wall lipopolysaccharide is the first-line diagnostic test to get Legionnaires disease [21, 22]. However , it detects onlyL. pneumophilaserogroup 1, which is the most virulent and most common cause of disease [11, 22, 23]. In Europe, > 90 % of Legionnaires disease cases were diagnosed by urinary antigen detection [2]. It is a rapid test (results available within hours), with a sensitivity of 5699 % [22], and it is positive within 4872.